Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New York, USA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight The overall frontotemporal dementia
Scientists are calling for stage 3 clinical trials of an Alzheimer's drug to be scrapped after a report highlighted serious doubts about the legitimacy of research that helped the medicine reach that stage.
SAVA stock is falling hard following the publication of a City University of New York report by Science regarding Hoau-Yan Wang.
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating ...
A professor at the City College of New York engaged in “significant research misconduct,” an expert committee concluded.